Jumo Health Announced the Launch of PRISM™
PRISM reframes trial execution by treating patient readiness as the primary driver of completion and predictability. Jumo Health, a Patient Experience Organization (PXO) today announced...
Category : Clinical Trials
TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics. TriNetX, driven by its vision of a...
Vaximm Appoints Sébastien Wieckowski, PhD, as CSO
Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies for cancer, today announced the appointment of Sébastien Wieckowski, PhD,...
Brillio Leads in HFS Horizons: Life Sciences Service Providers 2025 Report
Recognition underscores Brillio’s AI-driven innovation and measurable impact on health outcomes, cost, patient experience, and equity Brillio, The Enterprise AI Accelerator, today announced that it...
Adimab Records Another Year of Double-Digit Clinical Program Growth
11 New Clinical Programs in 20256 Partner Programs Have Reached the Market89 Total Clinical Programs Initiated to Date Adimab, LLC, the global leader in the...
GCCL and OPIS Collaborate to Advance Global Clinical Trial Capabilities
GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of...
Citeline, Risklick Partner to Improve Protocol Design and Optimization
Citeline’s Best-in-Class Data and AI Combine with Risklick’s End-to-End Digital Protocol Workflow Citeline, a leader in clinical solutions for the life sciences industry, and Risklick,...
Clonell™ Launches the Ultimate Regenerative Medicine Platform
Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world’s first ‘Patient-Specific Embryonic...
Novocure Appoints Company President Frank Leonard as CEO
Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as President of Novocure...
WCG CenterWatch Unveils Report Assessing AI Adoption in Clinical Research
WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the release of the WCG CenterWatch 2025 AI Benchmarking Report. Available...